Nivagen Pharmaceuticals, Inc.
Brijesh Pandya is a seasoned chemist with extensive experience in the pharmaceutical industry. Currently serving as a Senior Chemist at Nivagen Pharmaceuticals, Inc. since September 2018, Brijesh has previously held key positions such as Senior Research Scientist at Dorizoe Lifesciences Ltd. from April 2015 to September 2018, and Officer at SUN PHARMA for a brief period in late 2014. Additional roles include Senior Research Associate at Dorizoe Lifesciences Limited and Officer at Unimark Remedies Ltd. Brijesh began the career as a Trainee at Ultra Analytical Lab. Academically, Brijesh holds a Master’s degree in Organic Chemistry from Hemchandracharya North Gujarat University and a Bachelor’s degree in Chemistry from Gujarat University.
Nivagen Pharmaceuticals, Inc.
Nivagen is engaged in the development, acquisition, and sales of generic prescription drugs and over the counter products for the North American market. It envisions to deliver high-quality products at affordable prices by leveraging global partnerships with the best FDA approved manufacturing facilities across the world.The US genericprescription market is currently at approximately $60 billion, and over $120 billion's worth of products will be coming off of patent protection in the next 10 years. Nivagen believes that, with its strategic partnership model of global alliances with highly efficient pharmaceutical companies across the globe, they can provide cost savings to the consumer while creating value for all members of the supply chain.